VetSRev
Database of veterinary systematic reviews
Database of veterinary systematic reviews
Immunopharmacology and immunotoxicology (2021) 43: 674–679
DOI: 10.1080/08923973.2021.1979034
Furazolidone (FZD) is a widely used drug in human and veterinary medicine, and has antibacterial and antiprotozoal action. Although it is widely used as a therapy in various pathological conditions, studies on the efficacy of FZD associated with immune responses are still limited. In this review, we seek to describe which immunopharmacological responses are caused by the administration of FZD. The study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). A systematic review of clinical trials and in vitro and in vivo experimental studies was carried out, which resulted in 943 papers, of which 35 were considered eligible and, of these 35, 4 were selected for analysis. The studies listed indicated that administration of FZD can modulate pro- or anti-inflammatory pathways, with a probable increase in the expression of reactive oxygen species and a modulation of apoptotic pathways.
Feitosa IB, Mori B, Santos APAD, Villanova JCO, Teles CBG, & Costa AG. (2021). What are the immunopharmacological effects of furazolidone? A systematic review. Immunopharmacology and Immunotoxicology, 43(6), 674–679. https://doi.org/10.1080/08923973.2021.1979034 Animals, Humans, Adaptive Immunity/drug effects/*immunology, Anti-Infective Agents, Local/*pharmacology, Apoptosis/drug effects/*immunology, Cell Survival/drug effects/immunology, Furazolidone, Furazolidone/*pharmacology, Immunity, Innate/drug effects/*immunology, Reactive Oxygen Species/antagonists & inhibitors/immunology/metabolism